EUVIMEDEUVIMED entdecken
Crossref

Thyroarytenoid Muscle Resection for Adductor Spasmodic Dysphonia

Ryuichi Mochizuki

The Japan Journal of Logopedics and Phoniatrics · 2026 · 67 (3) · 213-220

DOI: 10.5112/jjlp.67.213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Japan Journal of Logopedics and Phoniatrics, 2026. Verfasst von Ryuichi Mochizuki.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adductor spasmodic dysphonia (AdSD) is a focal laryngeal dystonia in which hyperactivity of the thyroarytenoid muscle (TA) plays a central role in symptom manifestation. Botulinum toxin (BT) injection into the TA is widely regarded as the gold standard treatment, providing symptomatic relief through reversible muscle weakening. On the basis of a similar therapeutic concept, thyroarytenoid muscle resection (TAM) was introduced in 1998 as a surgical option aimed at the permanent reduction of TA function; however, its clinical adoption has been limited.The establishment of diagnostic criteria for spasmodic dysphonia in 2017 and the approval of BT injection for AdSD under public insurance coverage in Japan in 2018 have markedly changed the clinical environment surrounding AdSD. These advances have enabled the reversible evaluation of TA involvement and have facilitated more appropriate patient selection for surgical intervention.This review summarizes the concept, historical background, surgical technique, clinical outcomes, and current positioning of TAM in the treatment of AdSD.Previous studies have consistently reported the early postoperative improvement of spasmodic voice symptoms following TAM, with transient breathy hoarseness that generally resolves within several months. Long-term follow-up data indicate durable symptom control with low recurrence rates. Compared with type II thyroplasty, TAM appears particularly effective in improving core symptoms such as strained voice quality, although careful patient selection is essential owing to the irreversible nature of the procedure.With advances in diagnostic accuracy and the availability of BT injection as a preoperative assessment tool, TAM may be reconsidered as a rational and durable treatment option for selected patients with AdSD. Further discussion is warranted regarding its optimal indications and long-term role within contemporary treatment strategies.

Zitieren

APA

Mochizuki, R. (2026). Thyroarytenoid Muscle Resection for Adductor Spasmodic Dysphonia. The Japan Journal of Logopedics and Phoniatrics, 67(3), 213-220. https://doi.org/10.5112/jjlp.67.213

Vancouver

Mochizuki R. Thyroarytenoid Muscle Resection for Adductor Spasmodic Dysphonia. The Japan Journal of Logopedics and Phoniatrics. 2026;67(3):213-220. doi:10.5112/jjlp.67.213

BibTeX
@article{Mochizuki2026,
  author = {Mochizuki, Ryuichi},
  title = {Thyroarytenoid Muscle Resection for Adductor Spasmodic Dysphonia},
  journal = {The Japan Journal of Logopedics and Phoniatrics},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {213--220},
  doi = {10.5112/jjlp.67.213}
}
Kostenlos starten →